Bladder Cancer - Results from #620

REVIEW UroToday

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis. January 24, 2024

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer. January 24, 2024

Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility. January 24, 2024

Radiotherapy in metastatic bladder cancer. January 23, 2024

An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer. January 23, 2024

U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations January 22, 2024

Current gross examination and reporting patterns of post-neoadjuvant chemotherapy cystectomy specimens: Is it time for a standardized approach? January 22, 2024

Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes. January 22, 2024

Bladder-Preserving Trimodality Therapy With Capecitabine. January 19, 2024

Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making. January 19, 2024

Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer. January 18, 2024

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion. January 18, 2024

Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control. January 18, 2024

Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma. January 17, 2024

Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review. January 17, 2024

APOBEC - Pattern Mutations and Viral Infections in Bladder Cancer - Expert Commentary January 16, 2024

Ferring Announces Full Availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S. January 16, 2024

Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patterns. January 16, 2024

Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2. January 16, 2024

Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer. January 15, 2024

Page 32 of 517